In an individual carton of Taromentin 1000 mg + 200 mg (batch 2010525), a vial of Taromentin 500 mg + 100 mg (batch 1020525) was found, containing half the intended dose of active substances. A real risk to patient health due to insufficient therapeutic efficacy cannot be excluded. Potential effects: lack of treatment efficacy, risk of infection progression, disease complications.
Download the app and stay informed
Get instant notifications about recalled products and protect your family.
FAQ
Related